These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 17325482)
1. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Foroulis CN; Thorpe JA Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389 [TBL] [Abstract][Full Text] [Related]
3. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer]. Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391 [TBL] [Abstract][Full Text] [Related]
4. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Hornick JL; Mino-Kenudson M; Lauwers GY; Liu W; Goyal R; Odze RD Am J Gastroenterol; 2008 Jan; 103(1):38-47. PubMed ID: 18076737 [TBL] [Abstract][Full Text] [Related]
5. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M; Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958 [TBL] [Abstract][Full Text] [Related]
7. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Panjehpour M; Overholt BF Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927 [TBL] [Abstract][Full Text] [Related]
9. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus. Gray J; Fullarton GM Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112 [TBL] [Abstract][Full Text] [Related]
10. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia. Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171 [TBL] [Abstract][Full Text] [Related]
11. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019 [TBL] [Abstract][Full Text] [Related]
12. The role of photodynamic therapy in the esophagus. Gross SA; Wolfsen HC Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793 [TBL] [Abstract][Full Text] [Related]
13. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy. Davila ML Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498 [TBL] [Abstract][Full Text] [Related]
15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Wolfsen HC; Woodward TA; Raimondo M Mayo Clin Proc; 2002 Nov; 77(11):1176-81. PubMed ID: 12440553 [TBL] [Abstract][Full Text] [Related]
17. Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. Wolfsen HC Gastrointest Endosc; 2005 Oct; 62(4):499-503. PubMed ID: 16185960 [No Abstract] [Full Text] [Related]
18. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862 [TBL] [Abstract][Full Text] [Related]
19. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665 [TBL] [Abstract][Full Text] [Related]
20. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]